Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure

International Journal of Cardiology

Volumn 76, Issue 2-3, 2000, Pages 125-133

  Rauchhaus, Mathias ^a,b   Koloczek, Veronika ^a   Volk, Hans Dieter ^c   Kemp, Michael ^a   Niebauer, Josef ^a   Francis, Darrel P ^a   Coats, Andrew J S ^a   Anker, Stefan D ^a,d  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Chronic heart failure; Cytokines; Endotoxin; Immune activation; Lipoproteins; Prognosis

Indexed keywords

CD14 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; RECEPTOR SUBTYPE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BODY MASS; CACHEXIA; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN TENSION; PRIORITY JOURNAL; PROGNOSIS;

ANALYSIS OF VARIANCE; ANTIGENS, CD14; CASE-CONTROL STUDIES; ENDOTOXINS; HEART FAILURE, CONGESTIVE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033694601     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00224-2     Document Type: Article

References (33)

1. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
2. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure
3. Tumor necrosis factor and steroid metabolism in chronic heart failure. Possible relation to muscle wasting
4. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
5. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure
6. Endotoxin and immune activation in chronic heart failure: a prospective cohort study
7. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy
8. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
9. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
10. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
11. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
12. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy
13. Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system
14. Interactions of endotoxin with human blood cells and serum proteins
15. Predictors of exercise capacity in chronic heart failure
16. Insulin resistance in chronic heart failure
17. The epidemiology of heart failure
18. Systemic inflammation in patients with heart failure
19. When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction
20. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure
21. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
22. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock
23. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice
24. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice
25. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins
26. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid
27. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia
28. Changes in serum lipoprotein pattern induced by acute infections
29. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock
30. Role for circulating lipoproteins in protection from endotoxin toxicity
31. Tlr4: central component of the sole mammalian LPS sensor
32. Plasma lipid concentrations correlate inversely with CPB-induced interleukin-6 release
33. Role of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure